This page includes the latest FDA filings for Intersect Ent Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | XENT | DUNS 876715355 |
Device Company | Device | Date |
---|---|---|
Intersect ENT, INC. | Other Medication | 2023-12-30 |
Intersect ENT, INC. | Other Medication | 2023-12-30 |
Intersect ENT, Inc. | Prescription Medication | 2023-01-27 |
Intersect Ent, Inc. | Propel | 2022-03-17 |
Intersect Ent, Inc. | PROPEL Mini Sinus Implant with Straight Delivery System | 2022-03-17 |
Intersect Ent, Inc. | Propel Mini | 2022-03-17 |
Intersect Ent, Inc. | Propel Contour | 2022-03-17 |
Intersect ENT, INC. | Other Medication | 2021-11-04 |
Intersect ENT, INC. | Other Medication | 2021-01-27 |
Intersect ENT, INC. | Other Medication | 2021-01-23 |
Intersect ENT, Inc. | Prescription Medication | 2020-05-08 |
Intersect ENT, INC. | Other Medication | 2019-11-14 |
Intersect ENT, INC. | Other Medication | 2018-12-12 |
Intersect ENT, Inc. | Sinuva | 2018-02-01 |
Intersect ENT, Inc. | Prescription Medication | 2018-02-01 |
INTERSECT ENT INC | 0000-00-00 00:00:00 |
NCAGE Code | 623E2 | INTERSECT ENT, INC.!DBA INTERSECT ENT |
CAGE Code | 623E2 | INTERSECT ENT, INC. INTERSECT ENT |
S.A.M. Registration | 623E2 [876715355] | INTERSECT ENT, INC. INTERSECT ENT |
SEC | 0001271214 | Intersect ENT, Inc. of DELAWARE |